Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -25.91% vs 19.49% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -68.41% vs 461.40% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -66.99% vs 296.31% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -8.57% vs 42.86% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of KYORIN Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -25.91% vs 19.49% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 6.37% vs 2.03% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -68.41% vs 461.40% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 137.29% vs 30.92% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -66.99% vs 296.31% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 50.71% vs 28.92% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -8.57% vs 42.86% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 255.56% vs 12.50% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






